Prof. Eija Kalso, MD, PhD is professor of pain medicine since 2004. She performed her postdoctoral studies at the University of Oxford with Sir Keith Sykes (1983–1984, pulmonary physiology & pharmacokinetics of opioids) and with Prof. H. J. McQuay, Oxford and A. H. Dickenson, UCL, London (spinal mechanisms of opioid analgesia and tolerance 1990–1991), and 1997 (evidence-based medicine with Prof. McQuay). In 1999 she worked at the Karolinska Institute with Prof. Martin Ingvar (placebo & opioid analgesia using PET).
Prof. Kalso has developed pain research in different fields: single and multi-centre clinical trials (acute, cancer and neuropathic pain) and evidence-based medicine, pharmacokinetics of opioids, basic pharmacology of opioids and α2-adrenergic agonists in different types of pain, imaging (PET, fMRI: opioid and placebo effects, neuropathic pain in HSV-patients, effects of chronic pain on the brain), and lately, genetics of pain and inter-individual variation in response to pain therapies, and the role of glial activation in opioid tolerance and neuropathic pain. She has published over 170 original articles and 2 patents. She is the immediate past president of the International Association for the Study of Pain.
Prof. Kalso leads a large research group of clinical and experimental pain research and is a Principal Investigator at the Institute of Biomedicine, Department of Pharmacology and Toxicology where she leads a pain pharmacology group.
Prof. Kalso’s role in GLORIA is the scientific and overall coordination of the project.
Mikko Airavaara • Viljami Jokinen • Eija Kalso • Oleg Kambur • Leena Karhinen • Mari Kaunisto • Zhilin Li • Tuomas Lilius • Vânia Moreira • Kert Mätlik • Pekka Rauhala • Maiju Rinne • Mart Saarma • Yulia Sidorova • Ilida Sulemanyova • Li Tian • Jaakko Vartia • Hanna Viisanen-Kuopila • Henri Xhaard • Jari Yli-Kauhaluoma